5 results
6-K
EX-99.1
GLPG
Galapagos NV
12 Nov 19
Current report (foreign)
6:15am
, filgotinib consistently improved clinical outcomes in bDMARD-IR patients and that treatment efficacy was not impacted by any of these demographic
20-F
2015 FY
GLPG
Galapagos NV
25 Mar 16
Annual report (foreign)
12:00am
was confirmed across a wide panel of parameters. Some imbalances among treatment groups in demographic and disease characteristics, as well as the limited … adjustments related to new demographic assumptions
Closing balance
The fair value of the plan assets developed as follows :
Year Ended December 31
DRS
GLPG
Galapagos NV
6 Feb 15
Draft registration statement
12:00am
among treatment groups in demographic and disease characteristics, as well as the limited size of each treatment group, may explain the relatively
- Prev
- 1
- Next